west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "YU Yuanlin" 1 results
  • Research Progress of Resistance Genes and Targeted Therapy for Gallbladder Carcinoma

    Objective To summarize the development of gallbladder carcinoma related resistance genes and targeted therapy. Methods Domestic and international publications online involving resistance genes and targeted therapy of gallbladder carcinoma in recent years were collected and reviewed. Results Recent studies had shown that chemotherapy drug resistance of gallbladder carcinoma mainly involved lysosome protein transmembrane β4 (LAPTM4B) gene, NF-E2-related factor 2 (Nrf2) gene, and cancer stem cells (CSCs). While the latest gene targets of treatment for gallbladder carcinoma mainly involved LAPTM4B, Nemo-like kinase (NLK), tissue factor way inhibitor-2 (TFPI-2), vascular endothelial growth factor-D (VEGF-D), epidermal growth factor receptor (EGFR), and melanoma differentiation-associated gene 7/interleukin 24 (mda-7/IL-24) gene. Conclusion The research involving resistance genes and targeted therapy of gallbladder carcinoma has make a certain progress, which broaden the concept of traditional treatment of gallbladder carcinoma.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content